Edition:
United States

Exact Sciences Corp (EXAS.OQ)

EXAS.OQ on NASDAQ Stock Exchange Capital Market

48.01USD
3:59pm EST
Change (% chg)

$-0.85 (-1.74%)
Prev Close
$48.86
Open
$48.47
Day's High
$49.74
Day's Low
$47.62
Volume
512,531
Avg. Vol
674,736
52-wk High
$63.60
52-wk Low
$19.93

Latest Key Developments (Source: Significant Developments)

Exact Sciences Offers $500 Mln Convertible Senior Notes Due 2025
Thursday, 11 Jan 2018 04:01pm EST 

Jan 11 (Reuters) - Exact Sciences Corp ::EXACT SCIENCES ANNOUNCES OFFERING OF $500 MILLION CONVERTIBLE SENIOR NOTES DUE 2025.  Full Article

Exact Sciences Says "Comfortable" With Current 2018 Consensus Revenue Estimate Of Around $417 Mln
Wednesday, 10 Jan 2018 08:09am EST 

Jan 10 (Reuters) - Exact Sciences Corp ::EXACT SCIENCES CORP SAYS "COMFORTABLE" WITH CURRENT 2018 CONSENSUS REVENUE ESTIMATE OF AROUND $417 MILLION.  Full Article

Exact Sciences Says On Dec. 15, Co, Unit Entered Loan, Security Agreement For 24-Month Secured Revolving Credit Facility For Up To $15.0 Mln
Monday, 18 Dec 2017 09:11am EST 

Dec 18 (Reuters) - Exact Sciences Corp ::EXACT SCIENCES - ON DEC. 15, CO, UNIT ENTERED LOAN, SECURITY AGREEMENT FOR 24-MONTH SECURED REVOLVING CREDIT FACILITY FOR UP TO $15.0 MILLION - SEC FILING.EXACT SCIENCES - ON DEC. 15, UNIT ENTERED LOAN AGREEMENT FOR A NON-REVOLVING CONSTRUCTION LOAN OF UP TO $25.6 MILLION.  Full Article

Exact Sciences reports qtrly loss per share of $0.23
Monday, 30 Oct 2017 04:05pm EDT 

Oct 30 (Reuters) - Exact Sciences Corp ::Exact Sciences Corp qtrly loss per share $0.23; qtrly revenue $72.6 million, up 158 percent.Exact Sciences Corp sees 2017 revenue of $254 million to $257 million.  Full Article

Exact Sciences posts Q2 loss per share $0.27
Tuesday, 25 Jul 2017 04:05pm EDT 

July 25 (Reuters) - Exact Sciences Corp :Q2 loss per share $0.27.Q2 earnings per share view $-0.35 -- Thomson Reuters I/B/E/S.Sees FY 2017 revenue $230 million to $240 million.Q2 revenue $57.6 million versus I/B/E/S view $49.8 million.FY2017 revenue view $211.2 million -- Thomson Reuters I/B/E/S.Exact Sciences Corp - anticipates completing at least 150,000 cologuard tests during Q3 of 2017.  Full Article

Exact Sciences laboratories enters national ancillary provider participation agreement with Unitedhealthcare Insurance
Wednesday, 5 Jul 2017 09:01am EDT 

July 5 (Reuters) - Exact Sciences Corp ::Exact Sciences Corp -Exact Sciences Laboratories entered national ancillary provider participation agreement with Unitedhealthcare Insurance for cologuard.Exact Sciences Corp - ‍exact and Aetna recently amended that agreement to include Aetna's commercial lines of business, effective July 15, 2017​.Exact Sciences Corp - additional terms of unitedhealthcare agreement are not disclosed .Exact Sciences Corp - additional terms of Aetna agreement, as amended, are not disclosed.  Full Article

Exact Sciences says offering of 7 mln common shares priced at $35 per share
Wednesday, 7 Jun 2017 07:46am EDT 

June 7 (Reuters) - Exact Sciences Corp :Exact sciences announces pricing of public offering of common stock.Says offering of 7.00 million common shares priced at $35.00per share.  Full Article

Exact Sciences reports agreement to sell 7 mln common shares
Tuesday, 6 Jun 2017 04:02pm EDT 

June 6 (Reuters) - Exact Sciences Corp ::Exact Sciences announces agreement to sell 7,000,000 common shares.Exact Sciences announces agreement to sell 7,000,000 common shares.Exact Sciences Corp - intends to use net proceeds of this offering to fund expansion of Cologuard commercialization activities.  Full Article

Exact Sciences posts Q1 loss per share $0.32
Thursday, 27 Apr 2017 06:00am EDT 

April 27 (Reuters) - Exact Sciences Corp :Q1 loss per share $0.32.Sees FY 2017 revenue $195 million to $205 million.Q1 revenue $48.4 million versus $14.8 million.Exact Sciences Corp - company anticipates revenue of $195 million-$205 million and completed Cologuard test volume of at least 470,000 tests during 2017.  Full Article

Mdxhealth and Exact Sciences sign collaboration agreement
Thursday, 27 Apr 2017 01:00am EDT 

April 27 (Reuters) - Mdxhealth Sa : :Mdxhealth and Exact Sciences sign collaboration agreement for collaboration in the growing field of epigenetics and molecular diagnostics.These acquisitions include one-time fees totaling $15 million, including payments accrued since July 2016.Exact Sciences is also acquiring Mdxhealth patents directed toward colorectal cancer.  Full Article

BRIEF-Exact Sciences announces upsize, pricing of $600 mln of 1 pct convertible senior notes due 2025

* EXACT SCIENCES ANNOUNCES UPSIZE AND PRICING OF $600 MILLION OF 1.0% CONVERTIBLE SENIOR NOTES DUE 2025